HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\)
Clinical trials for HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\) explained in plain language.
Never miss a new study
Get alerted when new HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\) trials appear
Sign up with your email to follow new studies for HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug camzyos may do more than clear Blockages—New study investigates
Disease control Recruiting nowThis study looks at whether the heart medication Camzyos (Mavacamten) can improve blood flow to the heart muscle in people with hypertrophic obstructive cardiomyopathy (HOCM). Researchers will use special PET-CT scans to measure blood flow before and after 12 months of treatment.…
Matched conditions: HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\)
Phase: NA • Sponsor: University of Manchester • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can better heart blood flow predict how far you can walk? new study investigates.
Knowledge-focused Recruiting nowThis study looks at 20 people with hypertrophic obstructive cardiomyopathy who are already on optimal medical therapy. Researchers want to see if changes in heart blood flow over one year are linked to changes in how far they can walk in six minutes. Participants will have two he…
Matched conditions: HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\)
Sponsor: Medical University of Vienna • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:55 UTC